Skip to main content
Top
Published in: Rheumatology International 7/2013

01-07-2013 | Original Article

Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis

Authors: Mehmet Ali Ulu, Remzi Çevik, Banu Dilek

Published in: Rheumatology International | Issue 7/2013

Login to get access

Abstract

To evaluate bone loss in the early- and late-stage ankylosing spondylitis (AS) patients using posteroanterior (PA) and lateral lumbar and femoral bone mineral density (BMD) measurement methods. Eighty-six AS patients and 50 control subjects were enrolled. PA spine, lateral spine, and femur BMD values of patients and controls were measured. The presence of any syndesmophytes or compression fractures was determined. Patients were divided as early (<10 years) and late stage (≥10 years) according to the onset of the inflammatory pain. Mean PA spinal BMD was similar in patients and controls (p = 0.460). Femoral and lateral spine BMD values were significantly lower in patients (p = 0.012 and p = 0.001). When comparing early- and late-stage AS groups, mean PA spinal BMD was found to be lower in the early group (p = 0.005), while femoral and lateral spinal values were lower (although statistically not significant) in the late group. At least one compression fracture was present in 28 % of patients. Although not statistically significant, mean PA spinal BMD was higher in those with fractures. Femoral and lateral spinal BMD values were significantly lower in the fracture group (p = 0.034 and p = 0.004). Lateral spinal BMD values were significantly lower in patients with syndesmophytes (p = 0.004). Bone loss is increased in AS compared with control subjects. The BMD measurement at the lateral lumbar spine reflects bone loss and fracture risk better than PA spine and femoral measurements.
Literature
1.
go back to reference El Maghraou A, Borderie D, Cherruau B, Edouard R, Roux C, Dougados M (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205–2209 El Maghraou A, Borderie D, Cherruau B, Edouard R, Roux C, Dougados M (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205–2209
2.
go back to reference Hanson CA, Shagrin JW, Duncan H (1971) Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop Rel Res 74:59–64 Hanson CA, Shagrin JW, Duncan H (1971) Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop Rel Res 74:59–64
3.
go back to reference Mitra D, Elvins DM, Speden DJ, Collins AJ (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology 39:85–89PubMedCrossRef Mitra D, Elvins DM, Speden DJ, Collins AJ (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology 39:85–89PubMedCrossRef
4.
go back to reference Will R, Palmer R, Bhalla AK, Ring F, Calin A (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2:1483–1485PubMedCrossRef Will R, Palmer R, Bhalla AK, Ring F, Calin A (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2:1483–1485PubMedCrossRef
5.
go back to reference O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1018PubMedCrossRef O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1018PubMedCrossRef
6.
go back to reference Reid DM, Nicoll JJ, Kenedy NS, Smith MA, Tothill P, Nuki G (1986) Bone mass in ankylosing spondylitis. J Rheumatol 13:932–935PubMed Reid DM, Nicoll JJ, Kenedy NS, Smith MA, Tothill P, Nuki G (1986) Bone mass in ankylosing spondylitis. J Rheumatol 13:932–935PubMed
7.
go back to reference Cooper C, Carbone L, Michet CJ, Atkinson EJ, O’Fallon W, Melton L (1994) Fracture risk in patients with ankylosing spondylitis: a population-based study. J Rheumatol 21:1877–1882PubMed Cooper C, Carbone L, Michet CJ, Atkinson EJ, O’Fallon W, Melton L (1994) Fracture risk in patients with ankylosing spondylitis: a population-based study. J Rheumatol 21:1877–1882PubMed
8.
go back to reference Devogelaer J-P, Dufour J, Huaux L, Deuxchaisnes C (1984) Appendicular and spinal bone mass in ankylosing spondylitis. Clin Rhematol 3:105 Devogelaer J-P, Dufour J, Huaux L, Deuxchaisnes C (1984) Appendicular and spinal bone mass in ankylosing spondylitis. Clin Rhematol 3:105
9.
go back to reference Mullaji AB, Upadhyay SS, Ho EK (1994) Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg Br 76:660–665PubMed Mullaji AB, Upadhyay SS, Ho EK (1994) Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg Br 76:660–665PubMed
10.
go back to reference Rubenstein H (1991) Osteoporosis in ankylosing spondylitis. Br J Rheumatol 30:160CrossRef Rubenstein H (1991) Osteoporosis in ankylosing spondylitis. Br J Rheumatol 30:160CrossRef
11.
go back to reference Calin A (1991) Osteoporosis and ankylosing spondylitis. Br J Rheumatol 30:318–319 Calin A (1991) Osteoporosis and ankylosing spondylitis. Br J Rheumatol 30:318–319
12.
go back to reference Mitra D, Elvins DM, Collins AJ (1999) Testesterone and TFI in mild ankylosing spondylitis. J Rheumatol 26:2414–2417PubMed Mitra D, Elvins DM, Collins AJ (1999) Testesterone and TFI in mild ankylosing spondylitis. J Rheumatol 26:2414–2417PubMed
13.
go back to reference Franck H, Meurer T, Lorenz CH (2004) Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 31:2236–2241PubMed Franck H, Meurer T, Lorenz CH (2004) Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 31:2236–2241PubMed
14.
go back to reference Spencer DG, Park WM, Dick HM, Papazoglu SN, Buchanan WW (1979) Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol 6:305–315PubMed Spencer DG, Park WM, Dick HM, Papazoglu SN, Buchanan WW (1979) Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol 6:305–315PubMed
15.
go back to reference Bessant R, Keat A (2002) How should clinicians manage osteoporosis in ankylosing spondylitis. J Rheumatol 29:1511–1519PubMed Bessant R, Keat A (2002) How should clinicians manage osteoporosis in ankylosing spondylitis. J Rheumatol 29:1511–1519PubMed
16.
go back to reference Bronson WD, Walker SE, Hilman LS, Keisler D, Hoyt T, Allen SH (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rhematol 25:929–935 Bronson WD, Walker SE, Hilman LS, Keisler D, Hoyt T, Allen SH (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rhematol 25:929–935
17.
go back to reference Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121PubMedCrossRef Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121PubMedCrossRef
18.
go back to reference Singh A, Bronson W, Walker SE, Allen SH (1995) Relative value of femoral and lumbar bone mineral density assesments in patients with ankylosing spondylitis. South Med J 88:939–943PubMedCrossRef Singh A, Bronson W, Walker SE, Allen SH (1995) Relative value of femoral and lumbar bone mineral density assesments in patients with ankylosing spondylitis. South Med J 88:939–943PubMedCrossRef
19.
go back to reference Will R, Palmer R, Bhalla AK, Ring F, Calin A (1990) Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol 29(6):498–499PubMedCrossRef Will R, Palmer R, Bhalla AK, Ring F, Calin A (1990) Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol 29(6):498–499PubMedCrossRef
20.
go back to reference Masud T, Langley S, Wiltshire P, Doyle D, Spector T (1993) Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 307:172–173PubMedCrossRef Masud T, Langley S, Wiltshire P, Doyle D, Spector T (1993) Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 307:172–173PubMedCrossRef
21.
go back to reference Gılgıl E, Kacar C, Tuncer T, Butun B (2005) The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis. J Rheumatol 32:292–294PubMed Gılgıl E, Kacar C, Tuncer T, Butun B (2005) The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis. J Rheumatol 32:292–294PubMed
22.
go back to reference Muntean L, Rojas-Vargas M, Font P, Simon SP, Rednic S, Schiotis R (2011) Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis. Clin Rheumatol 30:691–695PubMedCrossRef Muntean L, Rojas-Vargas M, Font P, Simon SP, Rednic S, Schiotis R (2011) Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis. Clin Rheumatol 30:691–695PubMedCrossRef
23.
go back to reference Yu W, Glüer C-C, Fuerst T, Grampp S, Li J, Lu Y et al (1995) Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int 57:169–174PubMedCrossRef Yu W, Glüer C-C, Fuerst T, Grampp S, Li J, Lu Y et al (1995) Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int 57:169–174PubMedCrossRef
24.
go back to reference Reid IR, Evans MC, Stapleton J (1992) Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res 7:1221–1225PubMedCrossRef Reid IR, Evans MC, Stapleton J (1992) Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res 7:1221–1225PubMedCrossRef
25.
go back to reference Karberg K, Zochling J, Sieper J, Felsenberg D, Braun JL (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32:1290–1298PubMed Karberg K, Zochling J, Sieper J, Felsenberg D, Braun JL (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32:1290–1298PubMed
26.
go back to reference Bessant R, Harris C, Keat A (2003) Audit of the diagnosis, assessment, and treatment of osteoporosis in patients with ankylosing spondylitis. J Rheumatol 30:779–782PubMed Bessant R, Harris C, Keat A (2003) Audit of the diagnosis, assessment, and treatment of osteoporosis in patients with ankylosing spondylitis. J Rheumatol 30:779–782PubMed
27.
go back to reference Wendling D (2005) Bone loss in ankylosing spondylitis: can we put the puzzle together? J Rheumatol 32:1184–1185PubMed Wendling D (2005) Bone loss in ankylosing spondylitis: can we put the puzzle together? J Rheumatol 32:1184–1185PubMed
28.
go back to reference Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364–368PubMedCrossRef Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364–368PubMedCrossRef
29.
go back to reference Başkan BM, Doğan YP, Sivas F, Bodur H, Özoran K (2010) The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol Int 30:375–381CrossRef Başkan BM, Doğan YP, Sivas F, Bodur H, Özoran K (2010) The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol Int 30:375–381CrossRef
30.
go back to reference Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L (2009) Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 44:772–776PubMedCrossRef Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L (2009) Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 44:772–776PubMedCrossRef
31.
go back to reference Borman P, Bodur H, Bingöl N, Bingöl S, Bostan E (2001) Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients: relationship to disease activity. J Clin Rheumatol 7:315–321PubMedCrossRef Borman P, Bodur H, Bingöl N, Bingöl S, Bostan E (2001) Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients: relationship to disease activity. J Clin Rheumatol 7:315–321PubMedCrossRef
Metadata
Title
Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis
Authors
Mehmet Ali Ulu
Remzi Çevik
Banu Dilek
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2632-9

Other articles of this Issue 7/2013

Rheumatology International 7/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.